Article Sidebar
Published:
Oct 5, 2006Keywords:
<i> Crossopteryx febrifuga Trypanosomiasis Trypanosoma. congolense</i>
Article Details
Issue
Section
Articles
Copyright of articles published shall reside exclusively with the Faculty of Pharmaceutical Sciences, University of Jos.
DECLARATION & COPYRIGHT TRANSFER
I/We the undersigned author(s) of article entitled
…………………………………………………………………………………………………………………
…………………………………………………………………………………………………………………
Declare as follows:
- The manuscript submitted to Journal of Pharmacy & Bioresources is original and has not been and will be published, whole or in part, in print or electronic format, in any other journal. It is also not being currently considered for publication in any journal.
- The submitted manuscript is a joint decision of all the coauthors.
- Each author has participated sufficiently in the work to warrant his or her inclusion in the list of authors. To this end, each author takes responsibility for appropriate portions of the manuscript.
- Authors have obtained necessary approval to carry out the experiments on animals and human subjects. Approval certificates will be furnished, if required by publishers or editors of the journal.
- Authors do not have any conflict of interest (financial or otherwise) other than those declared.
- If the manuscript is accepted for publication, the authors transfer and assign copyright of the article referenced above to Journal of Pharmacy and Bioresources.
Name & Signature of authors
1. 2.
- 4.
- 6.
- 8.
Corresponding authors name address, affiliation and email:
Main Article Content
Preliminary evaluation for anti-trypanosomal activity of aqueous stem bark extract of <i> Crossopteryx febrifuga</i> in <i>Trypanosoma congolense</i> - infected rats
Abstract
Aqueous stem bark extract of Crossopteryx febrifuga was evaluated for anti-trypanosomal activity in rats. Twenty four rats divided into four groups (A, B, C, D) of six animals per group were used. Infection with T. congolense was established after a pre-latent periods of 10 and 11 days for curative (Group B) and prophylaxis (Group A) studies respectively. Both Group A and Group B were treated orally with 1500mg/kg of the crude extract for five consecutive days. Parasitemia, Packed Cell Volume (PCV), Red Blood Cells (RBC) counts and Differential leucocytes (WBC) counts were monitored throughout the studies. Phytochemical analysis of the crude aqueous extract was also carried out. Anaemia developed with establishment of infection in all the groups. Analysis of PCV, RBC and Differential WBC counts showed no significant difference (P>0.05) between treated and untreated animals. The crude extract contains saponins, tannins, reducing sugars, volatile oils and alkaloids as phytochemicals. It showed no significant prophylaxis or curative against T. congolense infection in rats as traditionally claimed. Although the plant may be used locally in combination with other plants or ingredients or even other orthodox drugs, further work is needed to fully assess the claim of the use of Crossopteryx febrifuga stem bark in the management or treatment of animal trypanosomiasis.
Journal of Pharmacy & Bioresources Vol. 2(2) 2005: 111-115
Journal of Pharmacy & Bioresources Vol. 2(2) 2005: 111-115
